{"id":"11d93de0-ecbc-40c1-9cbf-78faec650556","companyId":"311e9cc4-68db-4d74-b74c-33fd30682fc4","modelName":"SAPIEN 3 Transcatheter Heart Valve","slug":"sapien-3-transcatheter-heart-valve","description":"The SAPIEN 3 is a transcatheter aortic heart valve system used for TAVR (transcatheter aortic valve replacement) to treat severe aortic stenosis without open-heart surgery. FDA-approved for low-risk patients since August 2019, and approved for asymptomatic patients in May 2025. Includes SAPIEN 3 Ultra and SAPIEN 3 Ultra RESILIA variants.","formFactor":"surgical","maturityStage":"production","lifecycleState":"active","supersededByModelId":null,"specs":{},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://en.wikipedia.org/wiki/Edwards_Lifesciences","title":"Edwards Lifesciences - Wikipedia","sourceName":"Wikipedia"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"keyFacts":[{"label":"S&P 500 Component","value":"Yes"},{"label":"Key Product","value":"Cordella Pulmonary Artery Sensor (FDA-approved June 2024 for heart failure management)"},{"label":"Manufacturing","value":"Irvine CA, Draper UT, Costa Rica, Singapore, Limerick Ireland, Moncada Spain (under construction)"}],"createdAt":"2026-07-07T11:06:51.948Z","updatedAt":"2026-07-08T20:01:39.696Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":null,"autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"jsonLd":{"@context":"https://schema.org","@type":"Product","@id":"https://registry.deploy.report/models/sapien-3-transcatheter-heart-valve","url":"https://registry.deploy.report/models/sapien-3-transcatheter-heart-valve","name":"SAPIEN 3 Transcatheter Heart Valve","description":"The SAPIEN 3 is a transcatheter aortic heart valve system used for TAVR (transcatheter aortic valve replacement) to treat severe aortic stenosis without open-heart surgery. FDA-approved for low-risk patients since August 2019, and approved for asymptomatic patients in May 2025. Includes SAPIEN 3 Ultra and SAPIEN 3 Ultra RESILIA variants.","identifier":"11d93de0-ecbc-40c1-9cbf-78faec650556","category":"surgical","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":"production","lifecycle_state":"active","architectural_position":{"cohort":"surgical","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":1,"primary_source_types":["knowledge-base"]}}}